An Open-Label Extension Study To Assess The Long-term Safety And Tolerability Of ATN-103 In Subjects With Rheumatoid Arthritis
An Open-Label Extension Study To Assess The Long-term Safety And Tolerability Of ATN-103 In Subjects With Rheumatoid Arthritis
This open-label extension study will allow subjects who have completed either the 3242K1-2000-WW or 3242K1-2001-JA study to receive up to an additional 48 weeks of ATN-103 treatment and will provide data on the long-term safety and tolerability of ATN-103 in subjects with rheumatoid arthritis.
Inclusion Criteria:
Exclusion Criteria:
Yoshio-machi Iizuka-shi, Fukuoka, Japan
Honmachi, Higashiyama, Kyoto, Japan
Ureshino-machi, Ureshino-shi, Saga-ken, Japan
Midori-cho 2 Chome Tokorozawa-shi, Saitama, Japan
Shinanomachi, Shinjuku, Tokyo, Japan
Takaoka-shi, Toyama, Japan
Les Marais, Gauteng 0084, South Africa
Panorama, Western Cape 7500, South Africa